Abstract
Nuclear and cytosolic proteins are glycosylated on serine or threonine residues by O-linked β-N-acetylglucosamine (O-GlcNAc). O-GlcNAc modification is one of various posttranslational modifications and seems to be involved in the modulation of transcription and signal transduction. Accumulating data suggest a role for O-GlcNAc-modified proteins in diabetes, acting as a glucose sensor. It has been suggested that the hexosamine biosynthetic pathway is involved in the mechanism causing insulin resistance and diabetic complications. Excess glucose entering into the hexosamine biosynthetic pathway might cause elevated O-GlcNAc modification of various proteins. In this article, we review the current data regarding the relationship between O-GlcNAc modification and diabetes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akimoto, Y., Hart, G., Hirano, H. et al. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes. Med Mol Morphol 38, 84–91 (2005). https://doi.org/10.1007/s00795-004-0264-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00795-004-0264-1